Forty six aqueous extracts from 38 medicinal plant species belonging to different families were selected on the basis of their traditional medicinal use as antidiarrhoeic agents. They were submitted in a broad biological screening including antibacterial, antiamoebic and antispasmodic activities. The results of the testing have indicated that 37 extracts (80.43%), 33 (71.74%) and 32 (69.54%) exhibited some level of antibacterial, antiamoebic and antispasmodic activity respectively. Only 8 plant extracts (17.39%) would act as antidiarrhoeic agents by a triple pronounced antibacterial, antiamoebic and antispasmodic action. They include aqueous extracts from Euphorbia hirta whole plant, leaves of Psidium guajava and Tithonia diversifolia, root bark of Alchornea cordifolia, Heinsia pulchella, Paropsia brazzeana, Rauwolfia obscura and Voacanga africana.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0944-7113(99)80036-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- Entamoeba histolytica is a parasite causing intestinal amebiasis, particularly prevalent in tropical areas and a major health issue in developing countries. Traditional diagnostic methods can cause delays in treatment, exacerbating patient conditions.
- A case involving a 59-year-old HIV-positive man revealed how initial testing misdiagnosed his illness, but advanced diagnostics using the FilmArray GI Panel quickly identified E. histolytica in under an hour.
- The successful and prompt treatment with antiamoebic drugs significantly improved the patient's health, highlighting the importance of rapid diagnosis in managing gastrointestinal infections effectively.
Drug modifications: graphene oxide-chitosan loading enhanced anti-amoebic effects of pentamidine and doxycycline.
Parasitol Res
November 2024
Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Subang Jaya 47500, Selangor, Malaysia.
Acanthamoeba castellanii is the causative pathogen of a severe eye infection, known as Acanthamoeba keratitis and a life-threatening brain infection, named granulomatous amoebic encephalitis. Current treatments are problematic and costly and exhibit limited efficacy against Acanthamoeba parasite, especially the cyst stage. In parallel to drug discovery and drug repurposing efforts, drug modification is also an important approach to tackle infections, especially against neglected parasites such as free-living amoebae: Acanthamoeba.
View Article and Find Full Text PDFDiloxanide in amoebiasis management: Unravelling the mechanism of action and effectiveness.
Basic Clin Pharmacol Toxicol
January 2025
Department of Pharmacy, Faculty of Pharmacy, Universitas Borneo Lestari, Banjarbaru, Indonesia.
Article Synopsis
- Diloxanide is an effective treatment for asymptomatic amoebiasis, but its exact mechanism of action is not well understood despite its structural similarities to chloramphenicol.
- It operates by inhibiting protein synthesis in the E. histolytica parasite, preventing the formation of more virulent cysts, and achieving a parasite clearance rate of 81-96%.
- The study calls for further research into diloxanide's structure-activity relationship and suggests exploring new drug formulations and improved diagnostic methods to enhance treatment efficacy and reduce the risk of relapse.
Inhibition of choline kinase as an antiamoebic approach in Entamoeba histolytica infection.
Trop Biomed
December 2023
School of Health Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
Entamoeba histolytica is the parasite responsible for amoebiasis, which can result in amoebic colitis or amoebic liver abscess. Metronidazole has been the conventional treatment for intestinal amoebiasis, but concerns regarding resistance have emerged due to the identification of resistance pathways in E. histolytica.
View Article and Find Full Text PDFAntigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis.
Antimicrob Agents Chemother
January 2024
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.
The intestinal parasites and are major causes of morbidity and mortality associated with diarrheal diseases. Metronidazole is the most common drug used to treat giardiasis and amebiasis. Despite its efficacy, treatment failures in giardiasis occur in up to 5%-40% of cases.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!